-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Eiger BioPharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2017 to 2023.
- Eiger BioPharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2023 was $920K, a 34.1% increase year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.97M, a 37.7% increase from 2022.
- Eiger BioPharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.89M, a 3.67% increase from 2021.
- Eiger BioPharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $2.78M, a 0.29% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)